MAP2K1
PMID 7601337.
“Nef: "necessary and enforcing factor" in HIV infection”. Curr. HIV Res. 3 (1): 87–94. (2005). doi:10.2174/1570162052773013. PMID 15638726.
“Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system”. Immunol. Rev. 208: 30–49. (2006). doi:10.1111/j.0105-2896.2005.00327.x. PMID 16313339.
“Modelling thymic HIV-1 Nef effects”. Curr. HIV Res. 4 (1): 57–64. (2006). doi:10.2174/157016206775197583. PMID 16454711.
“ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts”. Cell Cycle 5 (14): 1514–8. (2006). doi:10.4161/cc.5.14.2981. PMID 16861903.
“Renaturation and partial peptide sequencing of mitogen-activated protein kinase (MAP kinase) activator from rabbit skeletal muscle”. Biochem. J. 285 (3): 701–5. (1992). doi:10.1042/bj2850701. PMC 1132850. PMID 1379797. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1132850/.
“Mitogen-activated protein kinase kinase 1 (MKK1) is negatively regulated by threonine phosphorylation”. Mol Cell Biol 14 (3): 1594–602. (1994). doi:10.1128/mcb.14.3.1594-1602.1994. PMC 358518. PMID 8114697. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC358518/.
“The MAPK signaling cascade”. FASEB J. 9 (9): 726–35. (1995). doi:10.1096/fasebj.9.9.7601337.